NEW YORK (GenomeWeb) — Epistem said today that it has entered into a collaborative funding agreement with the Global Health Investment Fund to support commercialization of Epistem's Genedrive molecular diagnostic platform and tuberculosis assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.